Enfortumab vedotin-ejfv 是一种
anti-Nectin-4 antibody-drug conjugate，用于尿路上皮癌的研究。
| 生物活性 |
Enfortumab vedotin-ejfv is ananti-Nectin-4 antibody-drug conjugatefor the management of urothelial carcinoma[1].
|
体外研究
(In Vitro) |
Enfortumab vedotin-ejfv is a fully human IgG1-kappa antibody conjugated to the microtubule-disrupting agent, monomethyl auristatin E (MMAE), via a protease-cleavable maleimidocaproyl valine-citrulline linker (SGD-1006)[2].
|
| Clinical Trial |
|
| 性状 |
|
| CAS 号 |
|
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis.
|
m.cnreagent.com
